PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Ironwood Pharmaceuticals, Inc. (IRWD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US46333X1081

CUSIP

46333X108

Sector

Healthcare

IPO Date

Feb 3, 2010

Highlights

Market Cap

$564.90M

EPS (TTM)

-$0.01

PEG Ratio

-0.26

Total Revenue (TTM)

$378.42M

Gross Profit (TTM)

$376.89M

EBITDA (TTM)

$106.14M

Year Range

$3.06 - $15.70

Target Price

$12.50

Short %

13.55%

Short Ratio

6.73

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
IRWD vs. IMVT IRWD vs. VOO
Popular comparisons:
IRWD vs. IMVT IRWD vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Ironwood Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-30.46%
7.20%
IRWD (Ironwood Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Returns By Period

Ironwood Pharmaceuticals, Inc. had a return of -66.08% year-to-date (YTD) and -64.73% in the last 12 months. Over the past 10 years, Ironwood Pharmaceuticals, Inc. had an annualized return of -10.83%, while the S&P 500 had an annualized return of 10.96%, indicating that Ironwood Pharmaceuticals, Inc. did not perform as well as the benchmark.


IRWD

YTD

-66.08%

1M

1.84%

6M

-30.47%

1Y

-64.73%

5Y*

-22.30%

10Y*

-10.83%

^GSPC (Benchmark)

YTD

23.00%

1M

-0.84%

6M

7.20%

1Y

24.88%

5Y*

12.77%

10Y*

10.96%

Monthly Returns

The table below presents the monthly returns of IRWD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202424.04%-33.54%-7.64%-11.02%-18.71%3.49%4.75%-25.92%-18.58%-4.13%-10.89%-66.08%
2023-7.02%-2.17%-6.65%-1.05%4.51%-2.21%4.23%-20.65%9.43%-6.85%10.37%15.56%-7.67%
2022-4.37%-3.50%16.91%-4.61%-6.08%2.31%-0.69%-6.03%-3.72%5.60%10.69%2.31%6.26%
2021-10.27%-9.69%21.13%-1.25%4.80%11.24%3.11%-1.28%-0.31%-2.22%-13.16%5.14%2.37%
2020-9.24%-0.33%-16.20%-0.89%-2.70%6.06%-11.14%10.14%-10.94%9.84%16.60%-1.13%-14.43%
201931.85%4.25%-4.99%4.99%-8.07%0.09%-2.83%-12.42%-7.79%16.95%19.72%10.73%53.49%
2018-1.20%-4.12%8.66%17.43%2.54%2.91%0.84%-0.21%-4.05%-29.04%5.50%-25.04%-30.89%
2017-5.95%17.45%1.01%-4.34%8.52%6.61%-5.98%-10.14%-1.13%-2.47%12.29%-13.20%-1.96%
2016-20.36%4.55%13.37%-4.48%19.52%4.68%8.07%-5.59%19.04%-19.58%22.20%-2.02%31.92%
20151.70%-0.83%3.56%-14.62%3.29%-14.53%-13.35%5.26%-5.27%9.02%7.39%-5.00%-24.35%
201419.47%4.61%-15.09%-10.55%29.95%7.05%-3.46%-12.57%0.12%8.22%-1.28%10.69%31.95%
201315.70%16.46%22.47%-16.82%-12.23%-25.62%23.26%-4.82%1.63%-18.88%18.90%1.66%4.78%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IRWD is 11, meaning it’s performing worse than 89% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of IRWD is 1111
Overall Rank
The Sharpe Ratio Rank of IRWD is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of IRWD is 1111
Sortino Ratio Rank
The Omega Ratio Rank of IRWD is 99
Omega Ratio Rank
The Calmar Ratio Rank of IRWD is 55
Calmar Ratio Rank
The Martin Ratio Rank of IRWD is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Ironwood Pharmaceuticals, Inc. (IRWD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for IRWD, currently valued at -0.84, compared to the broader market-4.00-2.000.002.00-0.841.83
The chart of Sortino ratio for IRWD, currently valued at -1.12, compared to the broader market-4.00-2.000.002.004.00-1.122.46
The chart of Omega ratio for IRWD, currently valued at 0.83, compared to the broader market0.501.001.502.000.831.34
The chart of Calmar ratio for IRWD, currently valued at -0.81, compared to the broader market0.002.004.006.00-0.812.72
The chart of Martin ratio for IRWD, currently valued at -1.16, compared to the broader market0.0010.0020.00-1.1611.89
IRWD
^GSPC

The current Ironwood Pharmaceuticals, Inc. Sharpe ratio is -0.84. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Ironwood Pharmaceuticals, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.84
1.83
IRWD (Ironwood Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Ironwood Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-78.00%
-3.66%
IRWD (Ironwood Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Ironwood Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ironwood Pharmaceuticals, Inc. was 81.06%, occurring on Nov 21, 2024. The portfolio has not yet recovered.

The current Ironwood Pharmaceuticals, Inc. drawdown is 78.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.06%Jul 18, 20181599Nov 21, 2024
-58.62%Mar 26, 2013724Feb 8, 2016326May 24, 20171050
-38.48%Jun 29, 201167Oct 3, 2011358Mar 8, 2013425
-38.43%Apr 14, 201094Aug 25, 2010159Apr 12, 2011253
-32.23%Jun 23, 2017156Feb 5, 2018104Jul 5, 2018260

Volatility

Volatility Chart

The current Ironwood Pharmaceuticals, Inc. volatility is 26.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
26.11%
3.62%
IRWD (Ironwood Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ironwood Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Ironwood Pharmaceuticals, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab